|
270 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
39 Trials |
|
5519 News |
|
| «12...910111213141516171819...110111» |
- | Trial completion, Surgery: Enhanced Recovery After Surgery: A RCT of Perioperative Management of Gynecologic Patients (clinicaltrials.gov) - Jul 12, 2017
P=N/A, N=40, Completed, Sponsor: Case Comprehensive Cancer Center
Active, not recruiting --> Completed
- | Trial completion, Enrollment change: Effects of PGS in Infertile Female Patients With RPL (clinicaltrials.gov) - Jul 11, 2017
P=N/A, N=189, Completed, Sponsor: ShangHai Ji Ai Genetics & IVF Institute
Active, not recruiting --> Completed Recruiting --> Completed | N=240 --> 189
- | Avastin (bevacizumab) / Roche, Torisel (temsirolimus) / Pfizer
Trial completion, Trial primary completion date, Metastases: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer (clinicaltrials.gov) - Jul 11, 2017
P2, N=252, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed | N=240 --> 189 Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> Mar 2017
- | triptorelin / Generic mfg.
Trial completion: GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT (clinicaltrials.gov) - Jul 7, 2017
P3, N=328, Completed, Sponsor: Centre Hospitalier Universitaire Ibn Rochd
Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> Mar 2017 Recruiting --> Completed
- | Enrollment closed, Preclinical: Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation (clinicaltrials.gov) - Jul 2, 2017
P=N/A, N=600, Active, not recruiting, Sponsor: Reproductive Medicine Associates of New Jersey
Recruiting --> Completed Enrolling by invitation --> Active, not recruiting
- | Enrollment closed: EnMotion, Embryo's Natural Motion (clinicaltrials.gov) - Jul 2, 2017
P=N/A, N=200, Active, not recruiting, Sponsor: Reproductive Medicine Associates of New Jersey
Enrolling by invitation --> Active, not recruiting Recruiting --> Active, not recruiting
- | Avastin (bevacizumab) / Roche
Trial completion, Metastases: Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer (clinicaltrials.gov) - Jul 2, 2017
P2, N=20, Completed, Sponsor: University of Oklahoma
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Trial primary completion date: Fermented Wheat Germ Extract in Women With Ovarian Cancer (clinicaltrials.gov) - Jul 2, 2017
P=N/A, N=20, Recruiting, Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Active, not recruiting --> Completed Trial primary completion date: Dec 2017 --> Dec 2018
- | Trial completion: Microarray Analysis for Human Genetic Disease (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=1500, Completed, Sponsor: National Human Genome Research Institute (NHGRI)
Trial primary completion date: Dec 2017 --> Dec 2018 Active, not recruiting --> Completed
- | Trial completion: The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome (clinicaltrials.gov) - Jun 30, 2017
P2, N=80, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Active, not recruiting --> Completed No longer recruiting --> Completed
- |||| Solithera (solithromycin) / Melinta Therap, Fujifilm Holdings
Trial primary completion date: SOLITAIRE-U: Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea (clinicaltrials.gov) - Jun 29, 2017
P3, N=300, Recruiting, Sponsor: Cempra Inc
No longer recruiting --> Completed Trial primary completion date: Apr 2017 --> Aug 2017
- ||| progesterone / Generic mfg.
Enrollment closed, Trial primary completion date, Head-to-Head: Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer (clinicaltrials.gov) - Jun 28, 2017
P4, N=1170, Active, not recruiting, Sponsor: Shady Grove Fertility Reproductive Science Center
Trial primary completion date: Apr 2017 --> Aug 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2017 --> May 2018
- || Trial primary completion date, HEOR: HSCMyomecty: Effectiveness of Truclear on Patient Quality of Life (clinicaltrials.gov) - Jun 27, 2017
P=N/A, N=62, Recruiting, Sponsor: All For Women Healthcare, Illinois
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2017 --> May 2018 Trial primary completion date: Dec 2016 --> Aug 2017
- |||| iron dextran / Generic mfg.
Trial completion, Enrollment change: Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding (clinicaltrials.gov) - Jun 27, 2017
P2, N=69, Completed, Sponsor: Luitpold Pharmaceuticals
Trial primary completion date: Dec 2016 --> Aug 2017 Active, not recruiting --> Completed | N=40 --> 69
- Trial primary completion date: Study of Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis (clinicaltrials.gov) - Jun 27, 2017
P=N/A, N=9, Active, not recruiting, Sponsor: Revalesio Corporation
Active, not recruiting --> Completed | N=40 --> 69 Trial primary completion date: Dec 2016 --> Dec 2017
- ||| Trial completion, Enrollment change, Trial primary completion date: FILM: A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping (clinicaltrials.gov) - Jun 23, 2017
P=N/A, N=180, Completed, Sponsor: Novadaq Technologies Inc.
Trial primary completion date: Dec 2016 --> Dec 2017 Recruiting --> Completed | N=150 --> 180 | Trial primary completion date: Mar 2017 --> Jun 2017
- | Trial completion, HEOR, Surgery: Lymphedema in Endometrial Cancer (clinicaltrials.gov) - Jun 23, 2017
P=N/A, N=100, Completed, Sponsor: Duke University
Recruiting --> Completed | N=150 --> 180 | Trial primary completion date: Mar 2017 --> Jun 2017 Active, not recruiting --> Completed
- | lidocaine topical / Generic mfg.
Trial primary completion date: Study to Compare the Efficacy of Cognitive-behavioral Couple Therapy and Lidocaine for Provoked Vestibulodynia (clinicaltrials.gov) - Jun 22, 2017
P4, N=224, Recruiting, Sponsor: Universit
Active, not recruiting --> Completed Trial primary completion date: May 2017 --> May 2018
- | Trial completion, Enrollment change: Conducting Outreach to Improve Cervical Cancer Screening Rates Among Underscreened Patients (clinicaltrials.gov) - Jun 22, 2017
P=N/A, N=1100, Completed, Sponsor: Fenway Community Health
Trial primary completion date: May 2017 --> May 2018 Active, not recruiting --> Completed | N=5279 --> 1100
- || Elonva (corifollitropin alfa) / Organon
Trial completion, Trial primary completion date: OSSIE: Ovarian Stimulation Single Injection Elonva (clinicaltrials.gov) - Jun 21, 2017
P3, N=20, Completed, Sponsor: Flinders Fertility
Active, not recruiting --> Completed | N=5279 --> 1100 Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Jun 2017
- Enrollment open: INREG 1: Multi-point Intra-mucosal Injections of Cross-linked Hyaluronic Acid (DESIRIAL®) in the Vaginal Vestibule (clinicaltrials.gov) - Jun 21, 2017
P=N/A, N=20, Recruiting, Sponsor: Centre Hospitalier Universitaire de Nīmes
Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Jun 2017 Not yet recruiting --> Recruiting
- | Trial primary completion date: Using CHWs or Mailing Self Sampling Home Tests to Increase Cervical Cancer Screening in South Florida (clinicaltrials.gov) - Jun 21, 2017
P=N/A, N=700, Recruiting, Sponsor: University of Miami
Not yet recruiting --> Recruiting Trial primary completion date: May 2017 --> Dec 2017
- | Trial completion: CART-meso in Mesothelin Expressing Cancers (clinicaltrials.gov) - Jun 20, 2017
P1, N=19, Completed, Sponsor: University of Pennsylvania
Trial primary completion date: May 2017 --> Dec 2017 Active, not recruiting --> Completed
- | Enrollment change, Trial termination: FIV-INOPK: Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF) (clinicaltrials.gov) - Jun 16, 2017
P4, N=49, Terminated, Sponsor: Centre Hospitalier Departemental Vendee
Active, not recruiting --> Completed N=280 --> 49 | Recruiting --> Terminated; Difficulty recruiting
- | Biomarker, Trial completion, Enrollment change, IO biomarker: Standard Operating Procedures for Cervical (Pre)Cancer Biomarker Detection in First-void Urine (BM-SOP Study) (clinicaltrials.gov) - Jun 15, 2017
P=N/A, N=128, Completed, Sponsor: Universiteit Antwerpen
N=280 --> 49 | Recruiting --> Terminated; Difficulty recruiting Recruiting --> Completed | N=100 --> 128
- || Avastin (bevacizumab) / Roche
Trial primary completion date: BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian Cancer (clinicaltrials.gov) - Jun 14, 2017
P=N/A, N=63, Active, not recruiting, Sponsor: Hoffmann-La Roche
Recruiting --> Completed | N=100 --> 128 Trial primary completion date: Jun 2017 --> Sep 2017
- | epacadostat (INCB024360) / Incyte
Trial termination: A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy (clinicaltrials.gov) - Jun 14, 2017
P2, N=83, Terminated, Sponsor: Incyte Corporation
Trial primary completion date: Jun 2017 --> Sep 2017 Completed --> Terminated; Study was terminated by the sponsor for lack of evidence of superiority and slow study accrual.
- | Bravelle (urofollitropin) / Ferring
Enrollment change, Trial termination, Trial primary completion date: Pilot Study on the Effects of FSH Treatment on the Epigenetic Characteristics of Spermatozoa in Infertile Patients With Severe Oligozoospermia (clinicaltrials.gov) - Jun 12, 2017
P3, N=30, Terminated, Sponsor: Instituto de Investigacion Sanitaria La Fe
Completed --> Terminated; Study was terminated by the sponsor for lack of evidence of superiority and slow study accrual. N=45 --> 30 | Recruiting --> Terminated | Trial primary completion date: Sep 2017 --> Jun 2017; UNDER RECRUITMENT
- |||| HSV vaccine (GEN-003) / Genocea, Shionogi
Trial completion: Evaluating New Formulation of Therapeutic HSV-2 Vaccine (clinicaltrials.gov) - Jun 12, 2017
P2, N=131, Completed, Sponsor: Genocea Biosciences, Inc.
N=45 --> 30 | Recruiting --> Terminated | Trial primary completion date: Sep 2017 --> Jun 2017; UNDER RECRUITMENT Active, not recruiting --> Completed
- | Ovidrel (choriogonadotropin alfa) / EMD Serono, Orgalutran (ganirelix acetate) / Organon
Trial completion, Preclinical, Trial primary completion date: Effect of Treatment With Corifollitropin Alpha in Vitro Fertilization in Patients With Poor Ovarian Response. (clinicaltrials.gov) - Jun 12, 2017
P3, N=234, Completed, Sponsor: Instituto de Investigacion Sanitaria La Fe
Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Sep 2017 --> Jun 2017
- | Menopur (menotropin) / Ferring, Synarel (nafarelin) / Pfizer
Trial completion, Preclinical, Enrollment change, Trial primary completion date: Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro Fertilization (clinicaltrials.gov) - Jun 9, 2017
P=N/A, N=4, Completed, Sponsor: New Hope Fertility Center
Recruiting --> Completed | Trial primary completion date: Sep 2017 --> Jun 2017 Recruiting --> Completed | N=60 --> 4 | Trial primary completion date: Dec 2016 --> Jun 2017
- | Bravelle (urofollitropin) / Ferring
Trial primary completion date: Pilot Study on the Effects of FSH Treatment on the Epigenetic Characteristics of Spermatozoa in Infertile Patients With Severe Oligozoospermia (clinicaltrials.gov) - Jun 8, 2017
P3, N=45, Recruiting, Sponsor: Instituto de Investigacion Sanitaria La Fe
Recruiting --> Completed | N=60 --> 4 | Trial primary completion date: Dec 2016 --> Jun 2017 Trial primary completion date: Jan 2017 --> Sep 2017
- | Ovidrel (choriogonadotropin alfa) / EMD Serono, Orgalutran (ganirelix acetate) / Organon
Preclinical, Trial primary completion date: Effect of Treatment With Corifollitropin Alpha in Vitro Fertilization in Patients With Poor Ovarian Response. (clinicaltrials.gov) - Jun 8, 2017
P3, N=232, Recruiting, Sponsor: Instituto de Investigacion Sanitaria La Fe
Trial primary completion date: Jan 2017 --> Sep 2017 Trial primary completion date: Jan 2017 --> Sep 2017
- |||| topotecan / Generic mfg., gemcitabine / Generic mfg.
Trial completion: Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer (clinicaltrials.gov) - Jun 8, 2017
P2, N=75, Completed, Sponsor: GlaxoSmithKline
Trial primary completion date: Jan 2017 --> Sep 2017 Terminated --> Completed
- Trial primary completion date: Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium (clinicaltrials.gov) - Jun 8, 2017
P1, N=10, Recruiting, Sponsor: University of California, San Diego
Terminated --> Completed Trial primary completion date: Dec 2016 --> Nov 2017
- || RG7882 / Roche
Enrollment closed, Enrollment change: A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer (clinicaltrials.gov) - Jun 7, 2017
P1, N=100, Active, not recruiting, Sponsor: Genentech, Inc.
Trial primary completion date: Dec 2016 --> Nov 2017 Recruiting --> Active, not recruiting | N=75 --> 100
- | clomifene citrate / Generic mfg.
Enrollment change, Trial primary completion date: Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration (clinicaltrials.gov) - Jun 5, 2017
P2, N=13, Active, not recruiting, Sponsor: Weill Medical College of Cornell University
Recruiting --> Active, not recruiting | N=75 --> 100 N=134 --> 13 | Trial primary completion date: Jun 2014 --> Jun 2016
- | Trial completion: Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian Cancer (clinicaltrials.gov) - Jun 5, 2017
P1, N=30, Completed, Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
N=134 --> 13 | Trial primary completion date: Jun 2014 --> Jun 2016 Active, not recruiting --> Completed
- | Rezzayo (rezafungin for injection) / Cidara Therap, Mundipharma, Melinta Therap
Trial completion: Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization (clinicaltrials.gov) - Jun 4, 2017
P=N/A, N=32, Completed, Sponsor: Cidara Therapeutics Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | metformin / Generic mfg.
Trial completion, Phase classification, Enrollment change, Trial primary completion date: Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer (clinicaltrials.gov) - Jun 2, 2017
P, N=21, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed | Phase classification: PN/A --> P | N=30 --> 21 | Trial primary completion date: Sep 2018 --> May 2017
- | MIS416 / Amplia Therap
Trial primary completion date: Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (clinicaltrials.gov) - Jun 2, 2017
P1, N=12, Not yet recruiting, Sponsor: Roswell Park Cancer Institute
Active, not recruiting --> Completed | Phase classification: PN/A --> P | N=30 --> 21 | Trial primary completion date: Sep 2018 --> May 2017 Trial primary completion date: Aug 2017 --> Aug 2018
- | vilaprisan (BAY 1002670) / Bayer
Trial completion: Drug-drug Interaction Study Between Orally Administered Rifampicin and Vilaprisan (clinicaltrials.gov) - Jun 2, 2017
P1, N=12, Completed, Sponsor: Bayer
Trial primary completion date: Aug 2017 --> Aug 2018 Active, not recruiting --> Completed
- | Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Enrollment closed, Trial primary completion date: Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone (clinicaltrials.gov) - Jun 1, 2017
P=N/A, N=13, Active, not recruiting, Sponsor: University of Virginia
Active, not recruiting --> Completed Completed --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Aug 2018
- Enrollment change, Trial termination: Validation of BD Onclarity (clinicaltrials.gov) - Jun 1, 2017
P=N/A, N=28, Terminated, Sponsor: Becton, Dickinson and Company
Completed --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Aug 2018 N=1500 --> 28 | Active, not recruiting --> Terminated; Lower than anticipated rate of subject enrollment
- | Trial primary completion date, HEOR: Impact of Sonifilan on the Quality of Life in Patients With Cervical Cancer During Radiation or Chemoradiation Therapy (clinicaltrials.gov) - May 31, 2017
P1, N=200, Recruiting, Sponsor: Asan Medical Center
N=1500 --> 28 | Active, not recruiting --> Terminated; Lower than anticipated rate of subject enrollment Trial primary completion date: May 2014 --> Dec 2025
- | Trial primary completion date: Significance of Fluorescence Colposcopy With Autofluorescence Imaging for Cervical Cancer (clinicaltrials.gov) - May 31, 2017
P=N/A, N=80, Completed, Sponsor: Asan Medical Center
Trial primary completion date: May 2014 --> Dec 2025 Trial primary completion date: Dec 2013 --> Apr 2014
- | Trial primary completion date, FDG PET: ERRICC: Diagnostic Performance of 18F-FDG-PET and Diffusion-weighted MRI in the Assessment of Stage IB to IIB2 Cervical Squamous-cell Carcinoma Response to Concomitant Radiochemotherapy and Brachytherapy (clinicaltrials.gov) - May 31, 2017
P=N/A, N=148, Recruiting, Sponsor: Hospices Civils de Lyon
Trial primary completion date: Dec 2013 --> Apr 2014 Trial primary completion date: May 2017 --> May 2018
- Enrollment change, Trial primary completion date: Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer (clinicaltrials.gov) - May 31, 2017
P=N/A, N=40, Completed, Sponsor: Asan Medical Center
Trial primary completion date: May 2017 --> May 2018 N=200 --> 40 | Trial primary completion date: Jul 2015 --> Nov 2015
- | carboplatin / Generic mfg., docetaxel / Generic mfg.
Enrollment change, Trial primary completion date, Metastases: Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer (clinicaltrials.gov) - May 31, 2017
P2, N=43, Completed, Sponsor: Asan Medical Center
N=200 --> 40 | Trial primary completion date: Jul 2015 --> Nov 2015 N=110 --> 43 | Trial primary completion date: Sep 2013 --> Jun 2016
- carboplatin / Generic mfg., cisplatin / Generic mfg.
Enrollment change, Trial primary completion date, Metastases: Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer (clinicaltrials.gov) - May 31, 2017
P3, N=21, Terminated, Sponsor: Asan Medical Center
N=110 --> 43 | Trial primary completion date: Sep 2013 --> Jun 2016 N=154 --> 21 | Trial primary completion date: Nov 2013 --> May 2014